HELIX, INC. for HELIX, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 5, 2023 | $40,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 26, 2023 | $130,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
US H 1526 Medicare Hereditary Cancer USH2369 In Vitro Tests US S 765 Hereditary Cancer Genetic Testing Pharmacogenomic testing, insurance coverage opportunities for whole exome sequencing and specific testing for genetic diseases, opportunities to use genetic testing to justify insurance coverage for specific treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Medical/Disease Research/Clinical Labs MED
US S 2640 Disease X Act 2023, viral surveillance in general sequencing as it relates to discovery of Disease X, development of medical counter-measures
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES New | — |
Budget/Appropriations BUD
HR 812 Inflation Reduction Act, including Defense Health, Viral Surveillance funding, COVID Supplemental allocations And funding needs, reauthorization for the ability for certain agencies to pull appropriations and enter into contracts in relation to the Pandemic & All Hazards Preparedness Act Discussion Drafts, including wastewater surveillance, viral surveillance and sequencing, data modernization, Center for Forecasting and Analytics, ASPR
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Science/Technology SCI
Pharmacogenomic testing, insurance coverage opportunities for whole exome sequencing and specific testing for genetic diseases. And the regulation of lab developed tests. US H 1526 Medicare Hereditary Cancer USH2369 In Vitro Tests US S 765 Hereditary Cancer Genetic Testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Defense DEF
Coordination with public health and other entities around biosecurity efforts in viral surveillance and sequencing for known and unknown pathogens, including Disease X, data needed to develop medical countermeasures, and Defense Health funding inclusive of genetic testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.